(Q46647289)

23 December 2017

title

Increased incidence of interstitial pneumonia by CHOP combined with rituximab (English)

1 reference

23 December 2017

1 reference

6

1 reference

23 December 2017

Mitsune Tanimoto

8

object named as

Mitsune Tanimoto

1 reference

23 December 2017

Shunji Takahashi

5

object named as

Shunji Takahashi

1 reference

23 December 2017

Kiyohiko Hatake

9

object named as

Kiyohiko Hatake

1 reference

23 December 2017

author name string

Daisuke Ennishi

1

1 reference

23 December 2017

Yasuhito Terui

2

1 reference

23 December 2017

Masahiro Yokoyama

3

1 reference

23 December 2017

Yuko Mishima

4

1 reference

23 December 2017

Kazuma Ikeda

7

1 reference

23 December 2017

publication date

1 May 2008

1 reference

23 December 2017

International Journal of Hematology

published in

1 reference

23 December 2017

volume

87

1 reference

23 December 2017

page(s)

393-397

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s12185-008-0066-7

exact match

0 references

cites work

Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-008-0066-7

A case of interstitial pneumonia induced by rituximab therapy

21 January 2018

1 reference

12 December 2020

Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological

1 reference

12 December 2020

Interstitial pneumonitis related to rituximab therapy.

1 reference

12 December 2020

Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma

1 reference

12 December 2020

Acute interstitial pneumonitis during chemotherapy for haematological malignancy.

1 reference

12 December 2020

Fatal interstitial pneumonitis related to rituximab-containing regimen

1 reference

12 December 2020

Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity

1 reference

12 December 2020

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.

1 reference

12 December 2020

Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP

1 reference

12 December 2020

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

1 reference

12 December 2020

Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP)

1 reference

12 December 2020

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

1 reference

12 December 2020

Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy

1 reference

12 December 2020

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

12 December 2020

Acute respiratory distress syndrome during the third infusion of rituximab in a patient with follicular lymphoma

1 reference

12 December 2020

10.1007/S12185-008-0066-7

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

18409079

1 reference

23 December 2017